Stay updated on Open-Label Surufatinib in EU NET Patients Clinical Trial

Sign up to get notified when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Open-Label Surufatinib in EU NET Patients Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The page now shows a new revision number (v3.5.4) in place of the previous v3.5.3, indicating a backend update; the study details and layout remain unchanged.
    Difference
    0.0%
    Check dated 2026-05-17T08:58:09.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    The page’s footer/version indicator was updated from revision v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T18:12:42.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:23:44.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.3 to v3.5.0 for the study record. This appears to be a metadata update rather than a change to the core study content.
    Difference
    0.0%
    Check dated 2026-03-20T19:57:01.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. No study data or content were changed.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:45.000Z thumbnail image
  9. Check
    115 days ago
    Change Detected
    Summary
    Revision updates: added v3.4.2 and removed v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:50:32.000Z thumbnail image

Stay in the know with updates to Open-Label Surufatinib in EU NET Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Open-Label Surufatinib in EU NET Patients Clinical Trial page.